Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-02-11 4:46 pm Purchase | 13G | ESSA PHARMA INC EPIX | BB BIOTECH AG | 5,015,814 11.4% | 250,000 (+5.25%) | View |
| 2022-02-11 1:43 pm Purchase | 13G | ESSA PHARMA INC EPIX | JANUS HENDERSON GROUP PLC JHG | 3,404,707 7.7% | 3,404,707 (New Position) | View |
| 2022-02-10 5:27 pm Purchase | 13G | ESSA PHARMA INC EPIX | Soleus Capital LLC | 3,525,457 8.01% | 3,525,457 (New Position) | View |
| 2022-01-12 4:30 pm Sale | 13D | ESSA PHARMA INC EPIX | Clarus Lifesciences III L.P. | 2,187,912 4.96% | -1,291,202 (-37.11%) | View |
| 2021-08-23 4:55 pm Sale | 13G | ESSA PHARMA INC EPIX | DRIEHAUS CAPITAL MANAGEMENT LLC | 0 0% | -1,048,524 (Position Closed) | View |
| 2021-08-17 1:57 pm Purchase | 13G | ESSA PHARMA INC EPIX | BB BIOTECH AG | 4,765,814 10.8% | 2,780,000 (+139.99%) | View |
| 2021-07-02 09:18 am Purchase | 13G | ESSA PHARMA INC EPIX | RTW INVESTMENTS LP | 3,028,719 7.49% | 3,028,719 (New Position) | View |
| 2021-05-05 5:20 pm Purchase | 13G | ESSA PHARMA INC EPIX | BB BIOTECH AG | 1,985,814 5.1% | 1,985,814 (New Position) | View |
| 2021-02-16 09:42 am Unchanged | 13G | ESSA PHARMA INC EPIX | DRIEHAUS CAPITAL MANAGEMENT LLC | 1,048,524 5.03% | 0 (Unchanged) | View |
| 2021-02-16 09:15 am Purchase | 13G | ESSA PHARMA INC EPIX | DRIEHAUS CAPITAL MANAGEMENT LLC | 1,048,524 5.03% | 1,048,524 (New Position) | View |
| 2021-02-12 4:30 pm Purchase | 13G | ESSA PHARMA INC EPIX | Vivo Capital IX LLC | 1,562,603 4.7% | 152,089 (+10.78%) | View |
| 2021-02-12 4:19 pm Purchase | 13G | ESSA PHARMA INC EPIX | EVENTIDE ASSET MANAGEMENT LLC | 2,335,168 7% | 324,999 (+16.17%) | View |
| 2021-02-12 4:01 pm Purchase | 13G | ESSA PHARMA INC EPIX | Soleus Capital LLC | 3,474,658 9.99% | 630,471 (+22.17%) | View |
| 2021-02-12 2:32 pm Sale | 13G | ESSA PHARMA INC EPIX | Omega Fund IV L.P. | 777,996 2.3% | -1,004,155 (-56.35%) | View |
| 2021-02-11 5:20 pm Purchase | 13G | ESSA PHARMA INC EPIX | BIOTECHNOLOGY VALUE FUND L P | 3,705,289 11% | 1,064,724 (+40.32%) | View |
| 2020-11-06 4:31 pm Purchase | 13G | ESSA PHARMA INC EPIX | Vivo Capital IX LLC | 1,410,514 4.4% | 1,410,514 (New Position) | View |
| 2020-08-19 5:14 pm Purchase | 13G | ARVINAS INC ARVN | ORBIMED ADVISORS LLC | 1,177,483 4.1% | 188,683 (+19.08%) | View |
| 2020-08-06 4:22 pm Purchase | 13G | ESSA PHARMA INC EPIX | PFIZER INC PFE | 1,675,000 6% | 1,675,000 (New Position) | View |
| 2020-08-03 12:56 pm Purchase | 13G | ESSA PHARMA INC EPIX | Soleus Capital LLC | 2,844,187 9.99% | 721,214 (+33.97%) | View |
| 2020-02-14 2:39 pm Purchase | 13G | ESSA PHARMA INC EPIX | BIOTECHNOLOGY VALUE FUND L P | 2,640,565 12.7% | 1,310,865 (+98.58%) | View |